SCOTT SCHLACKMAN - 10 Mar 2023 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves attorney-in-fact
Issuer symbol
MED
Transactions as of
10 Mar 2023
Net transactions value
-$178,200
Form type
4
Filing time
14 Mar 2023, 18:09:08 UTC
Previous filing
09 Feb 2023
Next filing
11 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Options Exercise $60,896 +2,200 +30% $27.68 9,480 10 Mar 2023 Direct
transaction MED Common Stock Sale $239,096 -2,200 -23% $108.68 7,280 10 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MED Stock Option (Right to Buy) Options Exercise $0 -2,200 -63% $0.000000 1,300 10 Mar 2023 Common Stock 2,200 $27.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received 5,000 stock options on February 4, 2016 pursuant to the Medifast, Inc. Amended and Restated 2012 Share Incentive Plan. These options vested in three equal annual installments beginning on February 4, 2017.